Groowe Groowe / Newsroom / LLY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

LLY News

Eli Lilly & Co.

Remedium Bio Announces Initial Close of Series A Financing to Advance Durable Protein Therapeutics Platform Toward First-in-human Clinical Development

accessnewswire.com
LLY

Ascletis Announces Initiation of Two Phase I Studies in U.S. for the Treatment of Obesity: ASC36 Once-Monthly Injection, an Amylin Receptor Peptide Agonist, and ASC36_35FDC Once-Monthly Injection, a Co-Formulation of ASC36 and GLP-1R/GIPR Peptide Agonist

prnewswire.com
LLY

Cancer Monoclonal Antibodies Market Size & Share Analysis | Growth Trends and Forecasts (2026- 2031) | Covers Five Global Regions

globenewswire.com
BMY LLY AMGN PFE GSK REGN ABBV SEIC JNJ AZN MRK

Mediar Therapeutics Enters into a Collaboration and Option Agreement with Ono Pharma to Develop Novel Treatments for Fibro-inflammatory Diseases

prnewswire.com
LLY

Blacksmith Medicines Announces Publication in Journal of Medicinal Chemistry Highlighting Discovery of a Non-Hydroxamate LpxC Inhibitor

prnewswire.com
LLY

Form 8-K

sec.gov
LLY

Onsera Health Strengthens Cardiometabolic Care Delivery with Eli Lilly's(R) Oral GLP-1 Foundayo(R)

accessnewswire.com
LLY

Lilly reports second-quarter 2026 financial results, raises full-year guidance, and highlights continued growth and pipeline progress

prnewswire.com
LLY

PM360 Announces 2026 Lifetime Achievement Award Honoree, CMO of the Year, and Brand Champions

prnewswire.com
LLY JNJ BMY MRK REGN KURA BMRN TAK VRTX GSK AZN AMGN ABBV

TailorMed and RxSense Partner to Surface Manufacturer Copay Assistance Within Digital Pharmacy Marketplaces

accessnewswire.com
BMY SNY MRK LLY